Anti-.alpha.v.beta.3 integrin antibody antagonists
US6171588A · kind A · utility
43Cited by
14References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 1998 |
| Grant date | Jan 9, 2001 |
| Priority date | — |
| Expiry date | Apr 9, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibodies that recognize the .alpha..sub.v .beta..sub.3 integrin receptor complex, but do not significantly bind to .alpha..sub.IIb.beta..sub.IIIa, inhibit .alpha..sub.v.beta..sub.3 integrin-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.